Company
Medartis Holding AG
Headquarters: Basel, Switzerland
Employees: 684
CEO: Dr. Christoph Bronnimann
Market Cap
CHF984.2 Million
CHF as of July 1, 2023
US$1.10 Billion
Medartis Holding AG Categories
Switzerland
languages
Healthcare
languages
Medical Devices
Switzerland Healthcare
Switzerland Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$185.81 B |
Medtronic
|
$117.30 B |
|
Stryker Corporation
|
$111.71 B |
|
Boston Scientific Corporation
|
$75.41 B |
|
Edwards Lifesciences Corporation
|
$56.44 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
Stocks & Indices
Medartis Holding AG has the following listings and related stock indices.
Stock: SIX: MED